CAMK2 has been shown to activate NOTCH in human prostate cancer cells (Mamaeva et al., 2009) whereas SHP-2 has also been shown to genetically interact with notch signaling in Drosophila (Oishi et al., 2006). This evidence concerns the gene PTPN11 and prostate carcinoma.